Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yapei Liu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMC Genomics|September 5, 2013
Identification, expression, and comparative genomic analysis of the IPT and CKX gene families in Chinese cabbage (Brassica rapa ssp. pekinensis)Zhenning Liu, Yanxia Lv, Mei Zhang, et al.
Journal of the International AIDS Society|November 15, 2014
Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitorMartin Fisher, Cheryl McDonald, Graeme Moyle, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2014
Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairmentFrank A Post, Jonathan Winston, Jaime F Andrade-Villanueva, et al.
Plant Physiology|February 24, 2026
Genome-wide T3E analysis reveals key pathogenicity factors in Xanthomonas campestris pv. campestris strains with high virulence in BrassicaGuo Chen, Congcong Kong, Linping Wang, et al.
HIV Clinical Trials|December 1, 2014
Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairmentCheryl K McDonald, Claudia Martorell, Moti Ramgopal, et al.
The Plant Cell|April 19, 2020
Control of Grain Size and Weight by the GSK2-LARGE1/OML4 Pathway in RiceJia Lyu, Dekai Wang, Penggen Duan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2021
Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 TrialsChloe Orkin, Faiza Ajana, Cissy Kityo, et al.
The Journal of Infectious Diseases|March 28, 2013
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 resultsJoel E Gallant, Ellen Koenig, Jaime Andrade-Villanueva, et al.
HIV Research & Clinical Practice|July 16, 2019
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trialsYeon-Sook Kim, Shinichi Oka, Ploenchan Chetchotisakd, et al.
The Lancet. HIV|March 6, 2017
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority studyEdwin DeJesus, Moti Ramgopal, Gordon Crofoot, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Genomics|September 5, 2013
Identification, expression, and comparative genomic analysis of the IPT and CKX gene families in Chinese cabbage (Brassica rapa ssp. pekinensis)Zhenning Liu, Yanxia Lv, Mei Zhang, et al.
Journal of the International AIDS Society|November 15, 2014
Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitorMartin Fisher, Cheryl McDonald, Graeme Moyle, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2014
Elvitegravir/cobicistat/emtricitabine/tenofovir DF in HIV-infected patients with mild-to-moderate renal impairmentFrank A Post, Jonathan Winston, Jaime F Andrade-Villanueva, et al.
Plant Physiology|February 24, 2026
Genome-wide T3E analysis reveals key pathogenicity factors in Xanthomonas campestris pv. campestris strains with high virulence in BrassicaGuo Chen, Congcong Kong, Linping Wang, et al.
HIV Clinical Trials|December 1, 2014
Cobicistat-boosted protease inhibitors in HIV-infected patients with mild to moderate renal impairmentCheryl K McDonald, Claudia Martorell, Moti Ramgopal, et al.
The Plant Cell|April 19, 2020
Control of Grain Size and Weight by the GSK2-LARGE1/OML4 Pathway in RiceJia Lyu, Dekai Wang, Penggen Duan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2021
Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 TrialsChloe Orkin, Faiza Ajana, Cissy Kityo, et al.
The Journal of Infectious Diseases|March 28, 2013
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 resultsJoel E Gallant, Ellen Koenig, Jaime Andrade-Villanueva, et al.
HIV Research & Clinical Practice|July 16, 2019
Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trialsYeon-Sook Kim, Shinichi Oka, Ploenchan Chetchotisakd, et al.
The Lancet. HIV|March 6, 2017
Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority studyEdwin DeJesus, Moti Ramgopal, Gordon Crofoot, et al.
Pageof 2